Nonalcoholic fatty liver disease (NAFLD) has been linked with a number of extra hepatic diseases and could be a potential risk factor of decreasing bone mineral density. To determine whether Upper ...

Perhaps what’s even more surprising is that less than 5% of people who have it actually know they have it.

Steatotic liver disease (SLD), formerly named fatty liver disease, has a prevalence estimated at 30–38% in adults. Detection of SLD is important, since prompt initiation of treatment can stop disease ...

Siemens Healthineers is joining forces with Novo to help boost awareness and diagnosis of fatty liver disease. | Siemens Healthineers is joining forces with Novo to help boost awareness and diagnosis ...

PostMag talks to five bright and ambitious recipients of the AIA Scholarships initiative to find out what lies ahead for them: here, we meet Zara Chui, a doctoral researcher seeking early-warning ...

For patients with steatotic liver disease (SLD), the steatosis-associated fibrosis estimator (SAFE) score demonstrated the ...

As liver disease surges in the US, certain dietary factors have become increasingly clear. Dietitians have revealed to the ...

Just two therapies are available to treat MASH. The first was Madrigal Pharmaceuticals’ Rezdiffra (resmetirom), which was ...

A multi-state outbreak of a dangerous liver disease is being investigated by officials after more than three dozen people ...

Liver disease can develop quietly, but changes involving your eyes, urine, skin and energy levels may signal that something ...

Novo Nordisk announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2.4 mg) as the first approved treatment in Singapore for adults with ...

In animal studies, LUNAR 2.0 produced 30 times as much protein as its earlier technology. Arcturus believes this could allow ARCT-2601 to be given at lower doses or less frequently. Citi called ...